Chignard M - Search Results

1

Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia.

Ventura GM, Balloy V, Ramphal R, Khun H, Huerre M, Ryffel B, Plotkowski MC, Chignard M, Si-Tahar M. Ventura GM, et al. Among authors: chignard m. J Immunol. 2009 Jul 1;183(1):670-6. doi: 10.4049/jimmunol.0801497. Epub 2009 Jun 17. J Immunol. 2009. PMID: 19535624 Free article.

2

Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4.

Dubourdeau M, Athman R, Balloy V, Huerre M, Chignard M, Philpott DJ, Latgé JP, Ibrahim-Granet O. Dubourdeau M, et al. Among authors: chignard m. J Immunol. 2006 Sep 15;177(6):3994-4001. doi: 10.4049/jimmunol.177.6.3994. J Immunol. 2006. PMID: 16951362

3

Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway.

Pothlichet J, Chignard M, Si-Tahar M. Pothlichet J, et al. Among authors: chignard m. J Immunol. 2008 Feb 15;180(4):2034-8. doi: 10.4049/jimmunol.180.4.2034. J Immunol. 2008. PMID: 18250407

4

Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, Chignard M. Ramphal R, et al. Among authors: chignard m. J Immunol. 2008 Jul 1;181(1):586-92. doi: 10.4049/jimmunol.181.1.586. J Immunol. 2008. PMID: 18566425 Free PMC article.

5

TLR 5, but neither TLR2 nor TLR4, is involved in lung epithelial cell response to Burkholderia cenocepacia.

de C Ventura GM, Le Goffic R, Balloy V, Plotkowski MC, Chignard M, Si-Tahar M. de C Ventura GM, et al. Among authors: chignard m. FEMS Immunol Med Microbiol. 2008 Oct;54(1):37-44. doi: 10.1111/j.1574-695X.2008.00453.x. Epub 2008 Aug 1. FEMS Immunol Med Microbiol. 2008. PMID: 18680520 Free article.

6

Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4.

Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M. Guillot L, et al. Among authors: chignard m. J Immunol. 2002 Jun 15;168(12):5989-92. doi: 10.4049/jimmunol.168.12.5989. J Immunol. 2002. PMID: 12055204

7

Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2.

Chabot S, Koumanov K, Lambeau G, Gelb MH, Balloy V, Chignard M, Whitsett JA, Touqui L. Chabot S, et al. Among authors: chignard m. J Immunol. 2003 Jul 15;171(2):995-1000. doi: 10.4049/jimmunol.171.2.995. J Immunol. 2003. PMID: 12847272

8

Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis.

Balloy V, Huerre M, Latgé JP, Chignard M. Balloy V, et al. Among authors: chignard m. Infect Immun. 2005 Jan;73(1):494-503. doi: 10.1128/IAI.73.1.494-503.2005. Infect Immun. 2005. PMID: 15618189 Free PMC article.

9

Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

Balloy V, Si-Tahar M, Takeuchi O, Philippe B, Nahori MA, Tanguy M, Huerre M, Akira S, Latgé JP, Chignard M. Balloy V, et al. Among authors: chignard m. Infect Immun. 2005 Sep;73(9):5420-5. doi: 10.1128/IAI.73.9.5420-5425.2005. Infect Immun. 2005. PMID: 16113258 Free PMC article.

10

TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections.

Ramphal R, Balloy V, Huerre M, Si-Tahar M, Chignard M. Ramphal R, et al. Among authors: chignard m. J Immunol. 2005 Sep 15;175(6):3927-34. doi: 10.4049/jimmunol.175.6.3927. J Immunol. 2005. PMID: 16148139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters